Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
48.24
-0.72 (-1.47%)
Oct 14, 2025, 3:43 PM EDT - Market open
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $6.93 billion as of October 14, 2025. Its market cap has increased by 28.77% in one year.
Market Cap
6.93B
Enterprise Value
5.55B
1-Year Change
28.77%
Ranking
Category
Stock Price
$48.24
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $6.93B, an increase of 587.83%. That is a compound annual growth rate of 43.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 7.15B | 106.07% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |